Laparoscopic Versus Robotic Assisted Laparoscopic Sacrocolpopexy for Vaginal Prolapse
Primary Purpose
Pelvic Organ Prolapse
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
robotic laparoscopic sacrocolpopexy
Laparoscopic Sacral Colpopexy
Sponsored by
About this trial
This is an interventional treatment trial for Pelvic Organ Prolapse focused on measuring laparoscopy, robot, vaginal prolapse, sacrocolpopexy, sacral colpopexy
Eligibility Criteria
Inclusion Criteria:
- Women who are 21 years of age or greater
- Status post hysterectomy with apical vaginal prolapse POPQ stages II-IV (prolapse from 1cm proximal to the hymen to all points distal) that desire laparoscopic surgical management.
Exclusion Criteria:
- Patients that are not candidates for general anesthesia
- Inability to consent
- History of prior sacralcolpopexy
- Suspicious adnexal masses or other factors that may indicate pelvic malignancy
- History of pelvic inflammatory disease
- Morbid obesity (body mass index greater than or equal to 40)
- History of prior or need for concomitant rectopexy with sigmoid resection.
Sites / Locations
- Cleveland Clinic
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
2
1
Arm Description
Robotic Sacral Colpopexy
Laparoscopic Sacral Colpopexy
Outcomes
Primary Outcome Measures
Primary outcome: operative time from incision to closure.
Secondary Outcome Measures
Secondary outcomes: perioperative complications, hospital costs and post-operative patient outcomes (anatomic outcomes on physical examination and patient satisfaction using validated condition specific quality of life measures).
Full Information
NCT ID
NCT00551993
First Posted
October 30, 2007
Last Updated
February 18, 2014
Sponsor
The Cleveland Clinic
1. Study Identification
Unique Protocol Identification Number
NCT00551993
Brief Title
Laparoscopic Versus Robotic Assisted Laparoscopic Sacrocolpopexy for Vaginal Prolapse
Official Title
Conventional Laparoscopic Versus Robotic Assisted Laparoscopic Sacrocolpopexy: a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2014
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
November 2011 (Actual)
Study Completion Date
November 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Cleveland Clinic
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to conduct a trial of robotic assisted versus traditional laparoscopic sacrocolpopexy in the treatment of patients with vaginal prolapse.
Detailed Description
Although laparoscopic sacrocolpopexy (LscASC) has been demonstrated to yield comparable success rates to abdominal sacrocolpopexy (93-99%) for the surgical treatment of pelvic organ prolapse, it has not been widely adopted due to the increased operating time and steep learning curves associated with laparoscopic suturing and knot-tying. For these reasons, robotic systems have been advocated for this technique. The objective of this study is to conduct a prospective single-blinded randomized controlled trial of robotic assisted versus traditional LscASC in the treatment of patients with apical vaginal prolapse stages II-IV (prolapse from 1 cm proximal to the hymen to all points distal).
This is a prospective single-blinded randomized controlled trial. Robotic assisted LscASC will be performed using the da Vinci Surgical System (Intuitive Surgical Inc., Sunnyvale, CA, USA) in a similar manner as that described above for conventional laparoscopy. Data points recorded during the procedure will include: operating room time of entry and exit, time from incision to closure and time taken for the suturing aspect of the case. From this information, the operating room costs and anesthesia costs, i.e., the amount that a provider must pay for goods or services, will be calculated. Estimated blood loss, perioperative and post-operative complications, and number of days in the hospital will be studied as will cost-effectiveness and impact on HRQOL
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse
Keywords
laparoscopy, robot, vaginal prolapse, sacrocolpopexy, sacral colpopexy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
78 (Actual)
8. Arms, Groups, and Interventions
Arm Title
2
Arm Type
Active Comparator
Arm Description
Robotic Sacral Colpopexy
Arm Title
1
Arm Type
Active Comparator
Arm Description
Laparoscopic Sacral Colpopexy
Intervention Type
Procedure
Intervention Name(s)
robotic laparoscopic sacrocolpopexy
Intervention Description
Da Vinci Robot
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic Sacral Colpopexy
Intervention Description
Standard laparoscopy
Primary Outcome Measure Information:
Title
Primary outcome: operative time from incision to closure.
Time Frame
Primary outcome: will be obtained immediately at the end of each procedure.
Secondary Outcome Measure Information:
Title
Secondary outcomes: perioperative complications, hospital costs and post-operative patient outcomes (anatomic outcomes on physical examination and patient satisfaction using validated condition specific quality of life measures).
Time Frame
Secondary outcome: will be collected over the course of the first postoperative year
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Women who are 21 years of age or greater
Status post hysterectomy with apical vaginal prolapse POPQ stages II-IV (prolapse from 1cm proximal to the hymen to all points distal) that desire laparoscopic surgical management.
Exclusion Criteria:
Patients that are not candidates for general anesthesia
Inability to consent
History of prior sacralcolpopexy
Suspicious adnexal masses or other factors that may indicate pelvic malignancy
History of pelvic inflammatory disease
Morbid obesity (body mass index greater than or equal to 40)
History of prior or need for concomitant rectopexy with sigmoid resection.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie Fidela M Paraiso, MD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
21979458
Citation
Paraiso MFR, Jelovsek JE, Frick A, Chen CCG, Barber MD. Laparoscopic compared with robotic sacrocolpopexy for vaginal prolapse: a randomized controlled trial. Obstet Gynecol. 2011 Nov;118(5):1005-1013. doi: 10.1097/AOG.0b013e318231537c.
Results Reference
result
Learn more about this trial
Laparoscopic Versus Robotic Assisted Laparoscopic Sacrocolpopexy for Vaginal Prolapse
We'll reach out to this number within 24 hrs